The profound therapeutic effect against late-stage metastatic liver cancer by E. coli–sgMafb/Maf injection was also observed in MC38 colorectal cancer (CRC) and Lewis lung carcinoma (LLC) lung cancer liver metastases (Figure 4, G–K). Here, MAF is linked to lung carcinoma.